The benefits of human milk have been confirmed for preterm infants, due to its nutritional aspects and to its biologically active compounds. Oligosaccharides play an emerging leading role among these compounds. Mother's milk can sometimes be lacking for preterm infants; pasteurized donor milk represents therefore an important alternative. The aim of this study is to evaluate the effects of Holder pasteurization on the concentration and pattern of oligosaccharides in preterm human milk. Our results indicate that pasteurization does not affect the concentration or pattern of analyzed oligosaccharides.
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During the past decades several data have confirmed the great benefits of human milk, not only for healthy term infants, but also for Very Low Birth Weight (VLBW, birth weight < 1500 g) pretenn infants (1), due both to its well known nutritional aspects and to its biologically active compounds. Oligosaccharides play an emerging leading role among these compounds, for their prebiotic, immunomodulatory and antimicrobial effects. (2) Oligosaccharides are synthesized in the mammary gland by the sequential addition of monosaccharides (galactose, fucose, N-acetyl-glucosamine, sialic acid) to the lactose molecule by specific glycosyltransferases (3) . Oligosaccharides represent by quantity the third component of human milk (1.2 gldl), besides lipids (4 gldl) and lactose (7.3 g/dl) (4).
Fresh own mother's milk is the best feeding for VLBWI (5) . When mother's milk is unavailable or in short supply,pasteurized donor breast milk offers a safe alternative and is considered the next best choice (6) .
Pasteurization partially affects the nutritional and immunological properties of breast milk (7) ; however, in a clinical perspective, it is well known that pasteurized milk maintains a protective effect against necrotizing enterocolitis (8) and infections (9) (10) . Holder method is the most widely employed in human milk banks. This method inactivates immunological and anti-infectious factors; nevertheless, other key nutritional and biological compounds (11-12) are not affected by temperature.
Few data address how pasteurization affects milk concentration of oligosaccharides. The aim of this study is to evaluate the effects of Holder pasteurization on lactose concentration and on the pattern of 24 different oligosaccharides, quantitatively representing the large majority of those so far identified in human milk.
MATERIALS AND METHODS
Two samples of breast milk were collected simultaneously from mothers having delivered between " ". E. BERTINO ET AL. 23 and 36 weeks of gestational age. Ten mothers were included in the study. One of the two samples was immediately frozen at -20°C, while the other one was pasteurized, then frozen at -20°e. Pasteurization was performed with a Sterifeed Pasteuriser by Medicare Colgate Ltd (Cullompton, England) by the Holder method, which means heating milk at + 62.5°C for 30 minutes (6, 13) , then rapidly cooling the samples to lOoC within approximately 20 minutes, by immersion into cold water.
Sample preparation and analysis
Frozen milk was rapidly defrosted in running lukewarm water. One millilitre of milk was added to I ml of acetonitrile. After stirring, the sample was centrifuged at 4000 rpm for 15 min. The supernatant was then diluted tol :50 (v/v) with ultrapure water (water PLUS for HPLC) and filtered through a 0,22 urn membrane (Millipore, Bedford, MA, USA). By means of an autosampler AD40 Dionex (Sunnyvale, CA, USA) a 25 !ll milk sample was injected into a Dionex high performance anion exchange chromatography (HPAEC) DX 500 system. This system is formed by a CarboPac PA-1 (4x250 mm) column, a CarboPac PA (3x25 mm) guard-column and a electrochemical detector (ED40) with a gold electrode, and is supported by a PeakNet software. The separation was obtained according to Coppa et al. (14) . Compound peaks were identified by the retention times and quantified by comparison of the peak areas of the samples with those of authentic standards on a 25 III injection.
Statistical Analyses
Data are expressed as means ± standard deviation. Student's paired z-test was performed to compare the statistical differences of detected levels of lactose and oligosaccharides in both experimental groups (nonpasteurized and pasteurized milk). P < 0.05 was used to define statistical significance.
RESULTS
Mean concentration of lactose and total oligosaccharides before and after pasteurization is reported in Table I . The results did not show any statistically significant variation in the total amount of either oligosaccharides or lactose (p>O.05).
In Table II mean concentrations of core-, fucosyland sialyl-oligosaccharides are shown. Also in this case, their concentration remained unchanged after the pasteurization process. Chromatographic pattern of the 24 tested oligosaccharides also resulted unchanged before and after pasteurization in all the samples analyzed, as shown in Fig. 1 for one subject (sample n. 1) shown as an example.
DISCUSSION
Our study demonstrates that concentration and pattern of human milk oligosaccharides are not affected by Holder pasteurization.
Human milk oligosaccharides have a proven pre-biotic effect since they are resistant to digestion and reach the colon where undigested oligosaccharides are metabolized by the microflora, thus producing a "biomass effect" characterized by selective development of the bifidogenic flora (15) . Moreover, bacterial fermentation processes lead to the production of short-chain fatty acids that have a trophic effect on the intestinal mucosa (15) .
Milk oligosaccharides can also compete with cell receptors in binding pathogenic agents. They are in fact adhesion ligand analogs, since their structure mimics the carbohydrate portion of glycoproteins and glycolipids of epithelial cell membranes, inhibiting binding of pathogenic microorganisms to the infants epithelial cell surface (3), thus preventing pathogens from developing their full pathogenic potential. Furthermore, breast milk oligosaccharides have an immunomodulatory effect, as long as they reduce the formation of selectine-initiated plateletneutrophil complexes, leukocyte activation and transmigration (3) .
Pre-biotic, trophic, anti-microbial and immunomodulatory effects play a relevant role in feeding vulnerable preterm infants with mother's own milk and, according to our results, also with pasteurized donor human milk.
Two meta-analyses have shown a reduction in necrotizing enterocolitis incidence in preterm or low birthweight babies fed donor milk compared to those fed preterm formula (8, 16) . Although NEC pathophysiology is not completely clear, prematurity of the gut, impaired immunological defense, enteral feeding and bacterial gut colonization are associated factors. Human milk oligosaccharides can play a protective role due to their trophic effect on intestinal mucosa, their anti-adhesive and anti-microbial effect and their favourable effect on bifidogenic flora selective development.(15) An infant's inflammatory response has a relevant role in propagating NEC after a primary insult.
Since human milk oligosaccharides inhibit leukocyte adhesion at sites of inflammation and reduce formation of highly active platelet neutrophil complexes; also in this way they may contribute to the protection of breast-fed infants against NEC, as well as against other inflammatory diseases (2, 17) .
In conclusion, as far as oligosaccharides are concerned, our study confirms the persistence of the biological value of human milk even after pasteurization.
